PhD Monitor
/Detail
Medical and Biological Sciences● Open★ MSCAPreview

PhD Position: β-catenin inhibitors in colorectal cancer (MSCA-DN FlexCAT)

Join an EU-funded doctoral network to develop novel therapeutic inhibitors targeting β-catenin in colorectal cancer.

Best for:Best for life science graduates with a strong interest in cancer biology, Wnt signaling, and therapeutic development.

Amsterdam UMC · Amsterdam, Netherlands · R1 · First-stage researcher
More professors at Amsterdam UMC
Colorectal CancerWnt SignalingBeta-cateninTranscriptional RegulationDrug DiscoveryProtein Condensates
Deadline
Oct 31, 2026
17 days
Funding
Salaried
Competitive salary including Living Allowance, Mobility Allowance, and Family Allowance (if applicable).
Start date
flexible
Fixed-term
Location
Amsterdam
Netherlands

Overview

This PhD position is part of the Marie Skłodowska-Curie Actions (MSCA) Doctoral Network 'FlexCAT', which focuses on targeting flexible and disordered protein regions for therapeutic development. The successful candidate will investigate the oncogenic role of β-catenin in colorectal cancer, specifically evaluating how novel inhibitors affect Wnt signaling and nuclear condensate formation. The research involves a combination of cell-based assays, transcriptional profiling, and interactome analysis to identify translational therapeutic candidates. The project includes a planned secondment at the University of Milan to conduct mass spectrometry analysis of the β-catenin interactome.

PhDMSCACancer ResearchMolecular BiologyOncologyFlexCAT

What you'll do

  • Evaluate the efficacy of novel β-catenin inhibitors on Wnt pathway activation using reporter systems.
  • Assess phenotypic and transcriptional changes in colorectal cancer cell lines following inhibitor treatment.
  • Investigate changes in the β-catenin/RNA interactome mediated by therapeutic inhibitors.
  • Perform functional assays including clonogenicity and proliferation studies.
  • Collaborate with international partners and participate in a two-month secondment for mass spectrometry analysis.
  • Contribute to the design and improvement of β-catenin binders based on experimental feedback.

Requirements

Degree required: Master's degree in a relevant field such as Molecular Biology, Oncology, or Biomedical Sciences.

Degree offered: PhD

Language: English proficiency required.

Instruction: English

Required skills
  • Experience with cell culture and cancer cell line models.
  • Proficiency in molecular biology techniques related to transcriptional analysis.
  • Strong analytical skills for interpreting complex biological data.
  • Ability to work independently and within an international research network.
Nice to have
Experience with Wnt signaling pathway research.Familiarity with mass spectrometry or interactome analysis.Experience with reporter assays like TOP-Flash/GFP.
Eligibility
  • Must meet MSCA mobility requirements (not having resided or carried out main activity in the Netherlands for more than 12 months in the 3 years immediately prior to recruitment).
  • Must be in the first four years of research career (R1).

Funding & terms

Type
Salaried
Amount
Competitive salary including Living Allowance, Mobility Allowance, and Family Allowance (if applicable).
Duration
3 years
Programme
MSCA-DN FlexCAT
EU-FUNDEDEuropean Commission

How to apply

Deadline: 2026-10-31

Applications must be submitted through the official university portal. Ensure all required academic and professional documentation is attached to the application.

Documents required
  • CV
  • Cover letter
  • Academic transcripts
↗Apply on site
NL
Prof.
Nicolas Leveille
University Medical Center Amsterdam
Lab
University Medical Center Amsterdam
Amsterdam UMC
MSCA-DN FlexCATNetherlands
See the full position

Create a free profile to unlock your personal match score, the full requirements, funding details and how to apply — in English or Persian.

No card · 10 free AI match scores
Ready to apply?
17 days until the deadline — open this position on its website.